Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, debuts with $35 million in Series A financing led by Perceptive Xontogeny Venture Fund II (PXV Fund II) – and joined by Section 32 and GV. The funds will be used to commercialize the company’s mNGS-based infectious disease test – which was developed by world-renowned infectious disease experts at the University of California San Francisco (UCSF) Center for Next-Gen Precision Diagno

H.E.L Group, a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced it will relocate its Greater London global headquarters from Borehamwood to Hemel Hempstead, over summer 2023. Overseen by interim Operational Director, Damian Slater, the move to new purpose-designed facilities supports the Company’s continued expansion and plans for future growth. Located on the Centro Trading Estate, the 16,000 sq f

Orthofix Medical Inc. a leading global spine and orthopedics company, today announced the full commercial launch of the WaveForm® A interbody for Anterior Lumbar Interbody Fusion procedures. The WaveForm A interbody seamlessly integrates with the company’s Meridian ALIF system for treating patients in need of fusion due to degenerative disc disease. The proprietary wave-like design of the WaveForm A interbody provides a balance of strength, porosity and stability, with a large impla

InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems, was recognised as a Strong Performer in The Forrester Wave™: Data Management for Analytics, Q1 2023 that ranks top data management and analytics (DMA) vendors. The Forrester Wave Data Management for Analytics report evaluated DMA vendors based on 26 criteria that include architecture and data modelling capabilities, perform

SMi Systems, a company specializing in single molecule imaging and quantification technologies for biomedical research and diagnostics, has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research. SMi’s approach will allow diagnostic testing centres to rapidly detect biomarkers and enable earlier patient diagnosis for a range of life-threatening diseases. Alongside this, the technology will s

PartsSource®, the leading online healthcare marketplace for mission-critical products and services, today announces PartsSource Repair and Service Agreements. This customizable solution expands total healthcare technology management (HTM) capacity by consolidating multiple service contracts into a single, evidence-based agreement with maximum flexibility, lower costs, and vendor choice in a digitally powered, transparent service experience. The company revolutionized parts procu

Concert Health, a leading behavioral health medical group, today announced a partnership with Froedtert Health, a leading Wisconsin-based healthcare provider, to improve the quality of care for pediatric, women's health, and primary care patients. The partnership, which launched in Spring 2023, involves 30 providers in Manitowoc and Sheboygan counties. Concert Health specializes in the Collaborative Care Model, an evidence-based approach to identifying and treating patients with

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, and Neuro-Bio, an Oxford-based biotechnology company with a therapeutic focus on neurodegenerative disease, announce success in the development of Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer’s disease. Aptamer Group has successfully developed a panel of Optimer binders to a novel Alzheimer’s disease biomarker. The Optim

With immunotherapy emerging as one of the most important treatment options in oncology, GE HealthCare has today announced the first patient scanned in a Phase I clinical trial2 of a first-of-its kind fluorine-18 PET radiopharmaceutical ([18F]GEH200521) specific for CD8, which is expressed on CD8+  T cells - a subpopulation of white blood cells which fight cancer. There are around 5000 immunotherapies in development today1, almost all of which work by activating CD8+ T cells bot

AquiSense Technologies, a global leader of UV-C LED water disinfection systems, has announced the release of its latest product, the PearlAqua Micro A.  Believed to be the smallest UV-C LED water disinfection system in the world, the Micro A deploys AquiSense’s patented reactor technology and high-volume manufacturing capabilities into a very small footprint for dispensing applications. "We’re excited to bring the Micro A to the market," said Oliver Lawal,